Inspira Technologies Gains Major Approval for ART100 System Use

Inspira Technologies Gains Major Approval for ART100 System Use

Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) is a trailblazer in life-support and diagnostic solutions. The company has recently gained a substantial milestone, as its INSPIRA™ ART100 system was approved for clinical validation by Israel’s largest healthcare provider. This development empowers healthcare professionals to utilize this innovative device during critical organ transplant procedures.

A leading team of physicians at a prominent medical center is set to evaluate the INSPIRA ART100 system's effectiveness in complex organ transplant scenarios. This hands-on experience with advanced technology aims to enhance the viability of organs through superior blood oxygenation methods. The unique capabilities of the INSPIRA ART100 allow it to provide out-of-body blood oxygenation, a crucial support during the transplant process, extending even to recovery phases.

Significance of Clinical Validation

This new phase indicates a pivotal application for the INSPIRA ART100 system, granting the company invaluable feedback from distinguished specialists in the field. As these experts assess the performance of the system in rigorous transplant situations, the insights gained will be instrumental for the ongoing development of Inspira’s flagship INSPIRA ART500 system. Designed to oxygenate blood effectively and support vital organs during critical respiratory failures, this system is expected to significantly advance respiratory care.

Inspira’s Growing Recognition

According to Dagi Ben-Noon, Chief Executive Officer of Inspira Technologies, the endorsement from such a reputable healthcare institution underscores the growing interest and acceptance of their technology both locally and internationally. This initiative solidifies Inspira's commitment to innovate and collaborate with healthcare professionals, striving to uncover new applications for their technologies.

Regulatory Clearances and System Overview

The INSPIRA ART100 system achieved FDA 510(k) clearance for cardiopulmonary bypass procedures in May 2024, accompanied by the Israeli AMAR certification for similar procedures in July 2024. The advanced hardware and software underpinning the system are foundational for the development of the INSPIRA ART500, which aims to meet the demands of modern respiratory therapy by allowing patients to be alert while their oxygen levels are stabilized—without relying on mechanical ventilation.

About Inspira Technologies

Inspira Technologies is on the forefront of developing cutting-edge respiratory support and diagnostic devices. The INSPIRA ART500 system, in particular, aims to transform critical care practices by facilitating patient awareness during treatments while effectively managing oxygen without mechanical support. The company also boasts the FDA-cleared INSPIRA ART100 that has garnered approvals for cardiopulmonary bypass procedures both domestically and internationally. Furthermore, their innovative HYLA blood sensor technology aims to redefine blood monitoring by eliminating the need for invasive blood draws. The pipeline also includes other promising products such as the Single-use patient kit, currently undergoing development.

Frequently Asked Questions

What is the INSPIRA ART100 system used for?

The INSPIRA ART100 system is designed to provide out-of-body blood oxygenation, primarily to support patients during organ transplant procedures.

Who approved the use of the INSPIRA ART100 system?

Israel's largest healthcare provider has approved the INSPIRA ART100 system for clinical validation and hands-on use in transplant scenarios.

What certifications does the INSPIRA ART100 hold?

The system has received FDA 510(k) clearance and Israeli AMAR certification for cardiopulmonary bypass and ECMO procedures.

How does Inspira Technologies contribute to medical innovation?

Inspira Technologies is developing advanced respiratory support technologies that enhance patient care, such as the INSPIRA ART500 and HYLA blood sensor.

How can I learn more about Inspira Technologies?

For additional information about Inspira Technologies and their products, visit their official website.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.